Q4 presentation
for investors and analysts on May 28, at 10 am CET
Link to webcast:
Phone numbers:
Sweden: +46 (0) 8 5051 0031
UK: +44 (0) 207 107 06 13
USA: +1 (1) 631 570 56 13
Upcoming
events
Q2 report
Silent period prior to Q2 report
BofA Global Healthcare Conference 2025, London
Annual General Meeting 2025
Q1 report
Silent period prior to Q1 report
Annual Report 2024/25
Investor update 2025
Q4 report
Silent period prior to Q4 report
DNB Nordic-American Healthcare Conference, New York City
Jefferies Pan-European Mid-Cap Conference, London
Carnegie Healthcare seminar 2025, Stockholm
Morgan Stanley European Healthcare Conference, London
Q3 report
Silent period prior to Q3 report
J.P. Morgan Healthcare Conference, San Francisco
SEB Nordic Seminar, Copenhagen
Elekta Deep Dive event (digital)
Berenberg European Conference, London
Q2 report
Silent period prior to Q2 report
Annual General Meeting 2024
Q1 report
Silent period prior to Q1 report
Annual Report 2023/24
Q4 and year-end report
Silent period prior to Q4 report
ESTRO investor meeting, Glasgow
Carnegie Healthcare conference
Q3 roadshow London, SEB (digital)
Q3 roadshow Stockholm, SEB
Payment date for second dividend 22/23
Q3 report
Record date for second dividend 22/23
Silent period prior to Q3 report
SEB Nordic Seminar
JP Morgan Healthcare conference, San Fransciso
DNB healthcare conference
Berenberg European conference
Road show Stockholm
Q2 report
Silent period prior to Q2 report
Road show Munich
BofA Global Healthcare conference, London
KeplerChevreux Autumn conference, Paris
Morgan Stanley Healthcare conference, New York
Goldman Sachs Healthcare Conference, London
Carnegie Mid-cap conference, Stockholm
Annual General Meeting 2023
Q1 report
Silent period prior to Q1
JP Morgan European Healthcare Conference
Capital Markets Day 2023
Q4 report
Silent period prior to Q4 report
Jefferies pan-european mid-cap conference
Carnegie Healthcare Seminar, Stockholm
Payment date for proposed dividend
Record date for proposed dividend
Q3 report
Silent period prior to Q3 report
SEB Nordic Seminar, Copenhagen
J.P. Morgan Healthcare Conference, San Francisco
DNB Nordic Healthcare Conference, Oslo
Berenberg European Conference, Surrey/UK
BNP Paribas Exane DILS CEO Conference (digital)
Q2 roadshow, London, Carnegie
Q2 roadshow, Stockholm, SEB
Q2 report
Silent period prior to Q2 report
BofA Global Healthcare Conference, London
Morgan Stanley Global Healthcare Conference, New York
J.P. Morgan European Healthcare CEO Conference Call (digital)
Pareto Securities' Healthcare Conference, Stockholm
Goldman Sachs Medtech and Healthcare Conference, London
Payment date for proposed dividend
Record date for proposed dividend
Q1 roadshow, London, Jefferies (digital)
Annual General Meeting 2022
Q1 roadshow, Stockholm, SEB
Q1 report
Silent period prior to Q1 report
Annual Report 2021/22
Q4 roadshow, London
Q4 roadshow, Stockholm
Q4 and year-end report
ESTRO investor meeting, Copenhangen
Silent period prior to Q4 report
Jefferies Pan-European Mid-Cap Conference (virtual)
Oppenheim healthcare conference
Carnegie Nordic healthcare conference
Q3 roadshow, London
Q3 roadshow, US (digital)
Q3 roadshow, Stockholm
Q3 report
Silent period prior to Q3 report
JP Morgan healthcare conference (digital)
SEB Nordic seminar (digital)
Berenberg Conference (digital)
Danske Bank winter conference (digital)
Q2 road show, London (digital)
Q2 roadshow, Stockholm
Q2 report
Silent period prior to Q2 report
Q3 Report
”Orders improved significantly during Q3 with all regions contributing. The growth was supported by new product launches of Elekta Evo and Elekta ONE. We delivered a record high cash flow in the quarter. Net sales and profitability were negatively impacted by lower volumes in the U.S. and China and as a consequence, we are adjusting our full year guidance.”
2025-02-21Interim report, May - January 2024/25
Key figures (rolling 12m)
Annual Report
2024-07-05 Annual Report 2023/24
Subscribe to press releases
IR contact
Peter Nyquist, Head of IR, [email protected]
Martin Svensson, IR Manager, [email protected]